摩洛哥慢性阻塞性肺病的经济负担:疾病成本研究
Soumaya Benmaamar1, Btissame Es-Sabbahi2, Mohammed Taghyioullah Haiba2
1Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University, Fez.
概括
慢性阻塞性肺病 (COPD) 对摩洛哥经济造成重大负担. 这项研究发现了高的直接和间接成本,主要是由吸烟和疾病严重程度驱动的,突出了加强烟草控制的必要性.
科学领域:
- 肺部医学 肺部医学
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重大的全球经济挑战.
- 摩洛哥COPD的经济影响仍未得到充分研究,需要集中调查.
- 了解COPD成本对于制定有针对性的公共卫生干预措施至关重要.
研究的目的:
- 为了估计摩洛哥COPD的经济负担.
- 确定影响COPD相关成本的关键决定因素.
- 为制定有关烟草控制和COPD管理的政策决策提供信息.
主要方法:
- 一个基于患病率的疾病成本研究,采用自下而上的方法.
- 从摩洛哥159名COPD患者 (2021-2022) 采用问卷收集的数据.
- 采用社会视角,包括直接的健康成本 (DHC) 和因劳动生产率下降而产生的间接成本 (IC).
主要成果:
- 据估计,每年每名患者的DHC费用为1816.6美元,其中药品和住院治疗是主要组成部分.
- 每年IC平均每名患者709.5美元.
- 与疾病严重程度,严重恶化和吸烟状况 (当前/前) 显著相关的成本.
结论:
- 慢性肺炎对摩洛哥卫生系统造成了巨大的经济负担.
- 吸烟和疾病严重程度是高COPD成本的主要驱动因素.
- 加强烟草控制措施对于减轻摩洛哥COPD的经济影响至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


